top of page

COVID-19 Pandemic Hurt OUD Services and Urine Drug Testing Access

Updated: Mar 26

March 28, 2022

Ashley Gallagher, Assistant Editor

Access to buprenorphine among Medicaid beneficiaries was not affected during the pandemic.

The COVID-19 pandemic did not disrupt access to buprenorphine but did affect access to opioid use disorder (OUD) treatment services and urine drug testing, according to the results of a new study published in JAMA Health Forum. 1

For more information, visit:

bottom of page